Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

ClinicalTrials.gov ID: NCT01077700

Public ClinicalTrials.gov record NCT01077700. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 5, 2026, 11:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an efficacy and safety study evaluating an experimental treatment for cognitive deficits in adults with schizophrenia.

Study identification

NCT ID
NCT01077700
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Enrollment
214 participants

Conditions and interventions

Eligibility (public fields only)

Age range
20 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2010 (Type not available)
Primary completion
Jul 2011 (Actual)
Completion
Jul 2011 (Actual)
Last update posted
Jun 6, 2018

2010 – 2011

United States locations

U.S. sites
24
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
Site Reference ID/Investigator# 21662 Anaheim California 92804 —
Site Reference ID/Investigator# 21683 Garden Grove California 92845 —
Site Reference ID/Investigator# 21581 National City California 91950 —
Site Reference ID/Investigator# 45310 Norwalk California 90650 —
Site Reference ID/Investigator# 26400 Pasadena California 91106 —
Site Reference ID/Investigator# 21584 Pico Rivera California 90660 —
Site Reference ID/Investigator# 45312 Riverside California 92506 —
Site Reference ID/Investigator# 45309 San Diego California 92128 —
Site Reference ID/Investigator# 46603 Plantation Florida 33317 —
Site Reference ID/Investigator# 21681 Chicago Illinois 60640 —
Site Reference ID/Investigator# 26397 Shreveport Louisiana 71104-2136 —
Site Reference ID/Investigator# 21761 Pittsfield Massachusetts 01201 —
Site Reference ID/Investigator# 21591 St Louis Missouri 63139 —
Site Reference ID/Investigator# 26409 Brooklyn New York 11235 —
Site Reference ID/Investigator# 21588 Cedarhurst New York 11516 —
Site Reference ID/Investigator# 21589 Dayton Ohio 45417 —
Site Reference ID/Investigator# 26407 Oklahoma City Oklahoma 73103 —
Site Reference ID/Investigator# 21601 Philadelphia Pennsylvania 19131 —
Site Reference ID/Investigator# 26399 Charleston South Carolina 29407 —
Site Reference ID/Investigator# 21590 Austin Texas 78731 —
Site Reference ID/Investigator# 21582 Austin Texas 78754 —
Site Reference ID/Investigator# 26406 DeSoto Texas 75115 —
Site Reference ID/Investigator# 26402 Houston Texas 77008 —
Site Reference ID/Investigator# 27502 Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01077700, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 6, 2018 · Synced Oct 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01077700 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →